Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc.'s email is info@iconictherapeutics.com
and
Iconic Therapeutics, Inc.'s phone number is (650) 437-1000
.
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. It is a biopharmaceutical company that has an exclusive license on issued Yale University patents for a novel recombinant protein called hI-con1. hI-con1 binds tissue factor (TF), triggering natural killer cells to selectively destroy pathologic neovascular blood vessels. Such cells include choroidal neovascularization (CNV) associated with wet age-related macular degeneration (wet AMD) and TF-expressing cancer cells and tumor-associated patho...
read more
Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. It is a biopharmaceutical company that has an exclusive license on issued Yale University patents for a novel recombinant protein called hI-con1. hI-con1 binds tissue factor (TF), triggering natural killer cells to selectively destroy pathologic neovascular blood vessels. Such cells include choroidal neovascularization (CNV) associated with wet age-related macular degeneration (wet AMD) and TF-expressing cancer cells and tumor-associated pathologic blood vessels (PBV). In addition to this cell-mediated cytotoxicity, hI-con1 may also interrupt the positive feedback loop between tissue factor and vascular endothelial growth factor (VEGF), thereby reducing VEGF levels. Phase 1 studies with hl-con1 are complete and no dose limited toxicities were observed. Evidence of dose-related biologic activity was observed.
show less
Website | iconictherapeutics.com | |
Industry | Biotechnology | |
Location | South San Francisco, California, United States | |
Employees | 8 | |
Founded | 2002 |
HQ | 701 Gateway Blvd Suite 100 | |
Phone | (650) 437-1000 | |
info@iconictherapeutics.com | ||
Funding | 82,849,902 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | iconictherapeutics.com | |
Industry | Biotechnology | |
Location | South San Francisco, California, United States | |
Employees | 8 | |
Founded | 2002 | |
linkedin.com/company/iconic-therapeutics-inc- | ||
HQ | 701 Gateway Blvd Suite 100 | |
Phone | (650) 437-1000 | |
info@iconictherapeutics.com | ||
Funding | 82,849,902 USD |
Email Patterns for Iconic Therapeutics, Inc.
Top Competitors for Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. Questions
Where are Iconic Therapeutics, Inc.'s headquarters?
Iconic Therapeutics, Inc.'s headquarters are in 701 Gateway Blvd Suite 100
What is Iconic Therapeutics, Inc.'s phone number?
Iconic Therapeutics, Inc.'s phone number is (650) 437-1000
What is Iconic Therapeutics, Inc.'s official website?
Iconic Therapeutics, Inc.'s website is iconictherapeutics.com
How many employees are working in Iconic Therapeutics, Inc. right now?
Iconic Therapeutics, Inc. has
8 employees.
View the Email and Phone Numbers for all 8 working at Iconic Therapeutics, Inc..
What is Iconic Therapeutics, Inc.'s industry?
Iconic Therapeutics, Inc.'s industry is
Biotechnology
Who are Iconic Therapeutics, Inc.'s top competitors?
Iconic Therapeutics, Inc.'s top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Iconic Therapeutics, Inc.'s email address?
Iconic Therapeutics, Inc.'s email address is info@iconictherapeutics.com
What are Iconic Therapeutics, Inc.'s categories?
Iconic Therapeutics, Inc.'s categories are Biopharma, Biotechnology, Therapeutics
What is Iconic Therapeutics, Inc.'s location?
Iconic Therapeutics, Inc.'s location is
South San Francisco, California, United States
When was Iconic Therapeutics, Inc.'s founded?
Iconic Therapeutics, Inc.'s founding year is 2002
What is Iconic Therapeutics, Inc.'s funding?
Iconic Therapeutics, Inc.'s funding is 82,849,902 USD
What is Iconic Therapeutics, Inc.'s current status?
Iconic Therapeutics, Inc.'s current status is operating
Top Iconic Therapeutics, Inc. Employees
Vice President, Development Operations
rmoosecyn@gmail.com
+1408-257-8179
moosecyn@pacbell.net
+1650-437-1000
Investor
rvrule@rvrule.com
+1770-757-5749
Vice President Operations And Programs
jfriedman@quarkpharma.com
+1650-208-2924
Vice President, Development Operations
rmoosecyn@gmail.com
+1408-257-8179
moosecyn@pacbell.net
+1650-437-1000
Investor
rvrule@rvrule.com
+1770-757-5749